Latest News from: Johns Hopkins Medicine

Filters close
Newswise: World Renowned Geneticist and Sickle Cell Disease Expert Takes Helm of Genetic Medicine Department at Johns Hopkins
Released: 28-Dec-2021 9:00 AM EST
World Renowned Geneticist and Sickle Cell Disease Expert Takes Helm of Genetic Medicine Department at Johns Hopkins
Johns Hopkins Medicine

South African geneticist Ambroise Wonkam, M.D., Ph.D., D.Med.Sc., has been selected as Johns Hopkins Medicine’s director of the Department of Genetic Medicine and the McKusick-Nathans Institute of Genetic Medicine.

Newswise: Early Use of Convalescent Plasma May Help Outpatients with Covid-19 Avoid Hospitalization
Released: 21-Dec-2021 9:00 AM EST
Early Use of Convalescent Plasma May Help Outpatients with Covid-19 Avoid Hospitalization
Johns Hopkins Medicine

The results of a nationwide, multicenter clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health provides solid evidence for the use of plasma from convalescent patients — those who have recovered from the disease and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19 — as an early treatment

Newswise:Video Embedded scientists-create-mind-blowing-tool-to-see-millions-of-brain-cell-connections-in-mice
VIDEO
Released: 20-Dec-2021 5:00 PM EST
Scientists Create Mind-Blowing Tool to ‘See’ Millions of Brain Cell Connections in Mice
Johns Hopkins Medicine

To solve the mysteries of how learning and memory occur, Johns Hopkins Medicine scientists have created a system to track millions of connections among brain cells in mice — all at the same time — when the animals’ whiskers are tweaked, an indicator for learning.

   
Newswise: Pet Scans Help Guide Drug to Best Treat Orthopaedic Implant Bacterial Infections
Released: 16-Dec-2021 11:20 AM EST
Pet Scans Help Guide Drug to Best Treat Orthopaedic Implant Bacterial Infections
Johns Hopkins Medicine

Treating bacterial infections associated with orthopaedic implants has often been a case of too little, too late. The traditional therapy has been a combination of prolonged antibiotics, including rifampin, a 50-year-old drug that has been a staple in the global fight against tuberculosis and other bacterial diseases.

Released: 9-Dec-2021 9:55 AM EST
Johns Hopkins Investigators Win Life Sciences Award for Astropath Cancer Mapping Technology
Johns Hopkins Medicine

Johns Hopkins astrophysicist, Alexander Szalay, Ph.D., and Kimmel Cancer Center pathologist Janis Taube, M.D., M.Sc., received a Life Sciences 2021 award for AstroPath at this year’s Falling Walls Science Summit, an international event honoring research breakthroughs from across the globe.

Newswise: Large Field Hospital Study Shows Rapid Covid-19 Test Compares Solidly with PCR Detection
Released: 7-Dec-2021 11:20 AM EST
Large Field Hospital Study Shows Rapid Covid-19 Test Compares Solidly with PCR Detection
Johns Hopkins Medicine

REsearchers at Johns Hopkins Medicine, the University of Maryland Medical Center, the University of Maryland School of Medicine and four other collaborators report that a rapid antigen detection test for SARS-CoV-2, the virus that causes COVID-19, proved more effective than expected when compared with virus detection rates using the established standard test, the polymerase chain reaction (PCR) assay.

Released: 2-Dec-2021 8:00 AM EST
Mouse Study Suggests Manipulation of Certain Nerve Cells Can Help Regenerate Lost Heart Muscle
Johns Hopkins Medicine

Human heart muscle cells cease to multiply after birth, making any heart injury later in life a permanent one, reducing function and leading to heart failure. Now, however, Johns Hopkins Medicine researchers say they have new evidence from mouse experiments that manipulating certain nerve cells or the genes that control them might trigger the formation of new heart muscle cells and restore heart function after heart attacks and other cardiac disorders.

Released: 30-Nov-2021 12:10 PM EST
Johns Hopkins Study: Biosensor Barcodes Identify, Detail ‘Chatting’ Among Cancer Cells
Johns Hopkins Medicine

Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate and track products and materials. In a paper first posted online Nov. 26, 2021, in the journal Cell, researchers at Johns Hopkins Medicine and The Johns Hopkins University demonstrate how they can do the same thing at the molecular level, studying the ways cancer cells “talk” with one another.

Released: 30-Nov-2021 9:00 AM EST
Johns Hopkins Medicine Researchers Map the Cell Types of the Iris in Mice
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report they have genetically mapped the cell types that make up the mouse iris — the thin disc of pigmented tissue that, in humans, gives eyes their distinct colors.

Newswise: Clonal Hematopoiesis in Donor May Improve Bone Marrow Transplant Outcome
Released: 22-Nov-2021 8:00 AM EST
Clonal Hematopoiesis in Donor May Improve Bone Marrow Transplant Outcome
Johns Hopkins Medicine

Clonal hematopoiesis, a condition in which mutations associated with blood cancers are found in the blood of healthy people, is common with aging. When looking for appropriate stem cell/bone marrow donors, clinicians tend to stay away from older donors with clonal hematopoiesis (CH) because of concerns about passing potentially premalignant stem cells to the recipient.

Newswise: A Stunning 3d Map of Blood Vessels and Cells in a Mouse Skull Could Help Scientists Make New Bones
Released: 18-Nov-2021 11:00 AM EST
A Stunning 3d Map of Blood Vessels and Cells in a Mouse Skull Could Help Scientists Make New Bones
Johns Hopkins Medicine

Johns Hopkins Medicine scientists have used glowing chemicals and other techniques to create a 3D map of the blood vessels and self-renewing “stem” cells that line and penetrate a mouse skull. The map provides precise locations of blood vessels and stem cells that scientists could eventually use to repair wounds and generate new bone and tissue in the skull.

Newswise: Simultaneous Repair of Heart Valves May Benefit Some Adults
Released: 16-Nov-2021 11:20 AM EST
Simultaneous Repair of Heart Valves May Benefit Some Adults
Johns Hopkins Medicine

An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe leakage of the tricuspid valve (a section of the heart that directs blood from the right atrium to the ventricle) may benefit from having both valves repaired at the same time.

Newswise: Study Shows Immune Cells Against Covid-19 Stay High in Number Six Months After Vaccination
Released: 16-Nov-2021 11:00 AM EST
Study Shows Immune Cells Against Covid-19 Stay High in Number Six Months After Vaccination
Johns Hopkins Medicine

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination.

11-Nov-2021 9:00 AM EST
Study Adds Evidence That Altered Fat Metabolism, Enzyme, Plays Key Role in Lou Gehrig’s Disease
Johns Hopkins Medicine

A new study using genetically engineered mice and human cell and tissue samples has added to evidence that higher levels of inflammatory chemicals involved in fat metabolism occur in people with amyotrophic lateral sclerosis (ALS), the neuromuscular disorder, also known as Lou Gehrig’s disease.

11-Nov-2021 8:20 AM EST
Mouse Cell Studies Show That Correcting DNA Disorganization Could Aid Diagnosis and Treatment of Rare Inherited Diseases
Johns Hopkins Medicine

Hopkins Medicine researchers say they have found that a protein that helps form a structural network under the surface of the cell’s “command center” — its nucleus — is key to ensuring that DNA inside it remains orderly.

Released: 11-Nov-2021 2:45 PM EST
Flu Season Underway Amid Ongoing COVID-19 Pandemic
Johns Hopkins Medicine

For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.

Released: 11-Nov-2021 2:30 PM EST
New $20 Million Grant Will Help Johns Hopkins Develop Technologies for Healthy Aging
Johns Hopkins Medicine

Johns Hopkins has received a $20 million grant from the National Institute on Aging that will spur the development of artificial intelligence devices (AI) to improve the health of older adults and help them live independently for longer — a relatively untapped use of this technology.

Released: 10-Nov-2021 9:00 AM EST
Johns Hopkins Children’s Center Awarded Grant to Study COVID-19 Safety Measures in Schools
Johns Hopkins Medicine

As the COVID-19 pandemic continues, many children have returned to school in-person this year for the first time in 18 months. The instruction may be the same, but the classrooms look and feel much different with safety measures in place to help prevent spread of the virus. These precautions range from masking to keeping children with runny noses and coughs home from school.

Released: 9-Nov-2021 9:00 AM EST
Fat-Secreted Molecule Lowers Response to Common Cancer Treatment
Johns Hopkins Medicine

Leptin, a molecule produced by fat cells, appears to cancel out the effects of the estrogen-blocking therapy tamoxifen, a drug commonly used to treat and prevent breast cancers, suggests a new study led by researchers from the Johns Hopkins Kimmel Cancer Center.

Released: 8-Nov-2021 11:35 AM EST
Study Finds More Inflammation in Black Patients with Chronic Skin Disease
Johns Hopkins Medicine

Johns Hopkins researchers identified two distinct clusters of patients with PN: those who had increased inflammation in the blood, and those who did not but were more likely to have a history of spinal disease, which may sensitize the nerves. Identifying those with unique types of inflammation may help doctors provide more precise and personalized treatment for the disorder.

Released: 8-Nov-2021 11:15 AM EST
Immunotherapy-Chemotherapy Treatment Coupled with In-Depth Genomic Analyses Leads to Improved Survival for Patients with Mesothelioma
Johns Hopkins Medicine

Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural mesothelioma, a cancer of the tissues lining the lungs, according to a phase II clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Released: 4-Nov-2021 9:00 AM EDT
Johns Hopkins Medicine Receives New Distinction of Excellence for Treatment of Rare Diseases
Johns Hopkins Medicine

Johns Hopkins Medicine (JHM) has been designated a National Organization for Rare Disorders (NORD) Rare Disease Center of Excellence. The newly established designation recognizes centers who are leaders in the diagnosis and care of people with rare diseases. JHM shares the recognition with the Kennedy Krieger Institute.

Released: 3-Nov-2021 2:50 PM EDT
Combining Two ‘Old Therapies’ Packs a Powerful Punch Against Pediatric Brain Tumors
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine and Italy’s Catholic University of the Sacred Heart medical school have provided solid evidence that copper, the first metal used medicinally, may now have a new role — helping save children from a devastating central nervous system cancer known as medulloblastoma.

Released: 2-Nov-2021 10:05 AM EDT
Studies Find B7-H3 Protein a Novel, Promising Target for Prostate Cancer Treatments
Johns Hopkins Medicine

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies were presented recently at the European Society for Medical Oncology (ESMO) 2021 Conference.

Released: 1-Nov-2021 2:30 PM EDT
New Analysis: More U.S. Adults Identify as Disabled; Ethnic and Socioeconomic Disparities Persist
Johns Hopkins Medicine

A new analysis led by Johns Hopkins Medicine researchers finds that the number of U.S. adults who report they have a disability is 27%, representing 67 million adults, an increase of 1% since the data were last analyzed in 2016. In this new study, which used data collected in 2019, before the COVID-19 pandemic, the researchers found a wide array of disparities between socioeconomic and demographic factors that persists among those who identify as disabled and those who do not.

   
Released: 1-Nov-2021 2:00 PM EDT
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
Johns Hopkins Medicine

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

Released: 27-Oct-2021 10:00 AM EDT
Gut-Brain Connection Research Gets Boost of $8.9 Million
Johns Hopkins Medicine

Johns Hopkins Medicine is one of three research institutions with scientists awarded $8.9 million to study the growing body of evidence that Parkinson’s disease originates among cells in the gut and travels up the body’s neurons to the brain. The research aims to develop treatments to prevent or halt progression of the disease.

Released: 26-Oct-2021 11:00 AM EDT
Statins Likely Not Helpful In Reducing Covid-19 Mortality or Severity
Johns Hopkins Medicine

Findings from a recent Johns Hopkins Medicine-led study of nearly 4,500 patients hospitalized with COVID-19 over a four-month period provide a stronger case for a very different conclusion: Statins likely did not confer any impact — positive or negative — on COVID-related mortality and may be associated with an significantly increased risk — nearly 1 chance in 5 — of more serious illness.

Newswise: Back Pain Common Among Astronauts Offers Treatment Insights for the Earth-Bound
Released: 21-Oct-2021 8:00 AM EDT
Back Pain Common Among Astronauts Offers Treatment Insights for the Earth-Bound
Johns Hopkins Medicine

As more people travel into space, Johns Hopkins Medicine experts expect more physicians will see patients with space travel-related pain.

Released: 18-Oct-2021 11:30 AM EDT
10 Johns Hopkins Faculty Members Elected to National Academy of Medicine
Johns Hopkins Medicine

Ten faculty members of The Johns Hopkins University and Johns Hopkins Medicine have been elected to the National Academy of Medicine, an independent organization of leading professionals from diverse fields, including health, medicine and the natural, social and behavioral sciences. It serves alongside the National Academy of Sciences and the National Academy of Engineering as adviser for the nation and the international community.

Released: 18-Oct-2021 8:00 AM EDT
Johns Hopkins Medicine Receives First Federal Grant for Psychedelic Treatment Research in 50 years
Johns Hopkins Medicine

Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.

Released: 14-Oct-2021 9:00 AM EDT
Johns Hopkins Medicine’s Wilmer Eye Institute Establishes the Sanford and Susan Greenberg Center to End Blindness
Johns Hopkins Medicine

After losing his sight as a college student, Sanford “Sandy” Greenberg, an emeritus trustee of The Johns Hopkins University and Johns Hopkins Medicine, vowed to end blindness “permanently and for everyone.” Now, to further that goal, the Johns Hopkins Wilmer Eye Institute has launched the Sanford and Susan Greenberg Center to End Blindness.

Released: 14-Oct-2021 8:00 AM EDT
Young ‘Social Butterfly’ Takes on Life-Threatening COVID-19 Complication and Wins
Johns Hopkins Medicine

When 8-year-old Morgan Deitz, known for her “spunky” and “social” personality, came down with COVID-19 in late July 2021, the symptoms were no more than your average cold. “She was a little fatigued, had a runny nose and her throat was a little sore,” her mom, Lauren Deitz, recalls of the symptoms that lasted about two days.

Released: 12-Oct-2021 12:40 PM EDT
Scientists Report Evidence for a New — but Now Extinct — Species of Ancient Ground-Dwelling Sloth
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine and the Philadelphia College of Osteopathic Medicine report new evidence that some 5,000 years ago, a sloth smaller than a black bear roamed the forest floor of what is now the Dominican Republic in the Caribbean Sea, living a lowland life different from its cousins on the other side of the island.

7-Oct-2021 3:20 PM EDT
Most Violence-Related Injuries Involving Adolescents Occur from Family Violence at Home
Johns Hopkins Medicine

Researchers with Johns Hopkins Children’s Center found that more than half of all violence-related injuries in youth treated in the emergency department (ED) were due to family violence, including child maltreatment and physical fighting. Most events involved parents or guardians. The researchers also found the majority of family violence-related injury happened at home, and the proportion occurring at home significantly increased during the pandemic.

Released: 7-Oct-2021 12:05 PM EDT
A Cousin of Viagra Reduces Obesity by Stimulating Cells to Burn Fat, Study Shows
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity and fatty liver in mice and improves their heart function — without changes in food intake or daily activity.

Released: 30-Sep-2021 3:20 PM EDT
Young Transplant Recipients Have Better Covid-19 Vaccine Response Than Adult Counterparts
Johns Hopkins Medicine

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

Newswise: Experimental Drug Development Approach Points to Better Targeted Therapies for Treatment-Resistant Leukemia
Released: 27-Sep-2021 12:15 PM EDT
Experimental Drug Development Approach Points to Better Targeted Therapies for Treatment-Resistant Leukemia
Johns Hopkins Medicine

New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.

Released: 27-Sep-2021 11:40 AM EDT
Flu Season Returns Amid COVID-19 Pandemic: Johns Hopkins Medicine Experts Available
Johns Hopkins Medicine

Flu Season Returns Amid COVID-19 Pandemic: Johns Hopkins Medicine Experts Available

Newswise:Video Embedded researchers-define-chain-of-events-leading-to-dangerous-intestinal-disorder-in-preemies
VIDEO
Released: 22-Sep-2021 5:10 PM EDT
Researchers Define Chain of Events Leading to Dangerous Intestinal Disorder in Preemies
Johns Hopkins Medicine

In a study with mice reported today in the journal Science Translational Medicine, a Johns Hopkins Medicine research team has provided what may be the most definitive view to date of the biological process leading to necrotizing enterocolitis (NEC), a dangerous inflammatory disease that can destroy a premature infant’s intestinal lining and causes death in up to a third of the cases.

Released: 21-Sep-2021 10:25 AM EDT
Study Shows Use of Smartphone App Associated with Lower Hospital Readmission Rates for Heart Attack Survivors
Johns Hopkins Medicine

Data collected from a group of 200 heart attack survivors using a smartphone app designed to navigate the recovery process, such as medication management and lifestyle changes, showed that app users experienced hospital readmission within the first 30 days of discharge at half the rate of a comparable group given standard aftercare without the app.

Released: 20-Sep-2021 11:40 AM EDT
Scientists Find a Pair of Proteins Control Supply Lines That Feed Cancer Cells
Johns Hopkins Medicine

In human cancer cell and mouse studies, researchers from Johns Hopkins Medicine have found that a set of proteins work in tandem to build supply lines that deliver oxygen and nutrients to tumors, enabling them to survive and grow. The protein twosome, PADI4 and HIF-1, ramp up their activity under low-oxygen conditions that are typically found in a fast-growing tumor, allowing it to build new blood vessels that feed the cancer’s growth.

Released: 20-Sep-2021 9:50 AM EDT
Unique Aspects of Pancreatic Cancer Proteins Could Lead to Early Detection, New Treatments
Johns Hopkins Medicine

A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins.

7-Sep-2021 9:00 AM EDT
Food Science Meets Cell Science in Bid to Explain Inner Workings of Membrane-Free Cell Compartments
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report that food science principles have helped them determine how unusual droplets within cells stay organized and avoid dissolving into the rest of the cell’s gelatinous interior.

   
Released: 9-Sep-2021 9:00 AM EDT
Right Program Could Turn Immune Cells into Cancer Killers
Johns Hopkins Medicine

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different “program” that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Released: 7-Sep-2021 4:30 PM EDT
Study Shows Contact with Police May Be Detrimental to Health, Well-Being of Black Youth
Johns Hopkins Medicine

According to a Johns Hopkins Medicine study published today in JAMA Pediatrics, exposure to police — even in instances in which the officers are providing assistance — may be detrimental to the health and well-being of Black youth, especially males, and can be associated with poor mental health, substance use, risky sexual behaviors and impaired safety.

   
Released: 7-Sep-2021 11:05 AM EDT
Older Patients Benefit from Cancer Immunotherapies
Johns Hopkins Medicine

A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers at the Johns Hopkins Kimmel Cancer Center Convergence Institute suggests that older cancer patients could benefit as much as younger patients from cancer immunotherapies.



close
0.27001